Integrating the reverse Aslanger pattern with Littmann’s continuity, the patient was diagnosed with a high lateral, high-risk, occlusive myocardial infarction. The patient immediately received dual ...

A new study published in the journal of PloS One showed that although reoperative therapy with evolocumab with rosuvastatin ...

Data from the Recently Published GENIA Study Show that Genous Is Associated with Low Rates of Stent Thrombosis and Target Lesion Revascularization HONG KONG, OrbusNeich today reported clinical data ...

SAN DIEGO, CA — Is informed consent necessary to randomize patients with ST-segment elevation MI (STEMI) into clinical trials? That was the question two experts grappled with this week at the Society ...

ST-segment elevation myocardial infarction (STEMI) is associated with high morbidity and mortality, but timely reperfusion is known to result in dramatically improved patient outcomes. As many as 40% ...

ORLANDO, FL—Intracoronary abciximab does not reduce rates of death or myocardial infarction (MI) compared to standard intravenous (IV) administration of the glycoprotein IIb/IIIa inhibitor in patients ...

The conventional classification of acute myocardial infarction (AMI) into ST-segment elevation (STEMI) and non-ST-segment elevation (NSTEMI) has long guided clinical decision-making. However, emerging ...

Lead augmented vector right (aVR) is a useful measure in the diagnosis of ST-segment elevation acute myocardial infarction (STEMI), indicates a new analysis of data from the HERO-2 trial. “Lead aVR is ...

Specific measures using a Six Sigma approach led to sustained reduction of door-to-balloon times among patients with ST-segment elevation myocardial infarction (STEMI) in a community setting. Each ...

The clinical effect of routine intracoronary thrombus aspiration before primary percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI) is ...